Medical management of osteonecrosis of the hip: A review

HIP International

Volumn 21, Issue 4, 2011, Pages 385-392

  Rajpura, Asim ^a   Wright, Andrew C ^a   Board, Timothy N ^a  

^a WRIGHTINGTON HOSPITAL   (United Kingdom)

Author keywords

Avascular necrosis; AVN; Femoral head; Non operative; Osteonecrosis

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; ENOXAPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ILOPROST; STEROID;

DECOMPRESSION; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG MEGADOSE; ELECTROMAGNETIC FIELD; EXTRACORPOREAL SHOCKWAVE THERAPY; FEMORAL HEAD COLLAPSE; FEMUR HEAD; FEMUR HEAD NECROSIS; HEADACHE; HIP ARTHROPLASTY; HIP RADIOGRAPHY; HUMAN; HYPERBARIC OXYGEN; JOINT DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PULSED ELECTROMAGNETIC FIELD THERAPY; REVIEW; ULTRASOUND THERAPY; VASCULARIZATION;

ADULT; ANIMALS; ANTICOAGULANTS; DECOMPRESSION, SURGICAL; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTROMAGNETIC RADIATION; ENOXAPARIN; FEMUR HEAD; FEMUR HEAD NECROSIS; HUMANS; ILOPROST; LITHOTRIPSY; MIDDLE AGED; VASODILATOR AGENTS;

EID: 79961010607     PISSN: 11207000     EISSN: None     Source Type: Journal    
DOI: 10.5301/HIP.2011.8538     Document Type: Review

References (57)

1. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 1995; 77: 459-74.
2. Mankin HJ. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 1992; 326: 1473-9.
3. Malizos KN, Karantanas AH, Varitimidis SE, Dailiana ZH, Bargiotas K, Maris T. Osteonecrosis of the femoral head: etiology, imaging and treatment. Eur J Radiol 2007; 63: 16-28.
4. Ficat RP, Arlet J. Necrosis of the Femoral Head. In: Hungerford DS, ed. Ischaemia and necrosis of bone. Baltimore: Williams and Wilkins; 1980.
5. Gardeniers JWM. ARCO Report of the committee of staging and nomenclature. ARCO News Letter 1993; 5: 79-82.
6. Merle D'Aubigne R, Postel M, Mazabraud A, Massias P, Gueguen J, France P. Idiopathic necrosis of the femoral head in adults. J Bone Joint Surg Br 1965; 47: 612-33.
7. Hernigou P, Poignard A, Nogier A, Manicom O. Fate of very small asymptomatic stage-I osteonecrotic lesions of the hip. J Bone Joint Surg Am 2004; 86: 2589-93.
8. Lieberman JR. Core decompression for osteonecrosis of the hip. Clin Orthop Relat Res 2004; 418: 29-33.
9. Scully SP, Aaron RK, Urbaniak JR. Survival analysis of hips treated with core decompression or vascularized fibular grafting because of avascular necrosis. J Bone Joint Surg Am 1998; 80: 1270-5.
10. Koo KH, Kim R, Ko GH, Song HR, Jeong ST, Cho SH. Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression. J Bone Joint Surg Br 1995; 77: 870-4.
11. Mont MA, Carbone JJ, Fairbank AC. Core e decompression versus nonoperative management for osteonecrosis of the hip. Clin Orthop Relat Res 1996; 324: 169-78.
12. Lafforgue P. Pathophysiology and natural history of avascular necrosis of bone. Joint Bone Spine 2006; 73: 500-7.
13. Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am 2006; 88: 1117-32.
14. Glueck CJ, Fontaine RN, Gruppo R, et al. The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. Clin Orthop Relat Res 1999; 366: 133-46.
15. Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res 2001; 386: 19-33.
16. Zalavras CG, Malizos KN, Dokou E, Vartholomatos G. The 677C-->T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head. Haematologica 2002; 87: 111-2.
17. Glueck CJ, Freiberg RA, Sieve L, Wang P. Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clin Orthop Relat Res 2005; 435: 164-70.
18. Arlet J, Ficat P, Lartigue G, Tran MA. [Clinical research on intraosseous pressure in the upper femoral metaphysis and epiphysis in humans. Application to the diagnosis of ischemia and necrosis]. Rev Rhum Mal Osteoartic 1972; 39: 717-23.
19. Drescher W, Bunger MH, Weigert K, Bunger C, Hansen ES. Methylprednisolone enhances contraction of porcine femoral head epiphyseal arteries. Clin Orthop Relat Res 2004; 423: 112-7.
20. Lee JS, Roh HL, Kim CH, Jung JS, Suh KT. Alterations in the differentiation ability of mesenchymal stem cells in patients with nontraumatic osteonecrosis of the femoral head: comparative analysis according to the risk factor. J Orthop Res 2006; 24: 604-9.
21. Suh KT, Kim SW, Roh HL, Youn MS, Jung JS. Decreased osteogenic differentiation of mesenchymal stem cells in alcohol-induced osteonecrosis. Clin Orthop Relat Res 2005; 431: 220-5.
22. Yin L, Li YB, Wang YS. Dexamethasone-induced adipogenesis in primary marrow stromal cell cultures: mechanism of steroid-induced osteonecrosis. Chin Med J (Engl) 2006; 119: 581-8.
23. Cui Q, Wang Y, Saleh KJ, Wang GJ, Balian G. Alcohol-induced adipogenesis in a cloned bone-marrow stem cell. J Bone Joint Surg Am 2006; 88 (suppl 3): 148-54.
24. Astrand J, Aspenberg P. Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats. BMC Musculoskelet Disord 2002; 3: 19.
25. Bowers JR, Dailiana ZH, McCarthy EF, Urbaniak JR. Drug therapy increases bone density in osteonecrosis of the femoral head in canines. J Surg Orthop Adv 2004; 13: 210-6.
26. Little DG, Peat RA, McEvoy A, Williams PR, Smith EJ, Baldock PA. Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats. J Bone Miner Res 2003; 18: 2016-22.
27. Hofstaetter JG, Wang J, Yan J, Glimcher MJ. The effects of alendronate in the treatment of experimental osteonecrosis of the hip in adult rabbits. Osteoarthritis Cartilage 2009; 17: 362-70.
28. Agarwala S, Jain D, Joshi VR, Sule A. Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study. Rheumatology (Oxford) 2005; 44: 352-9.
29. Agarwala S, Shah S, Joshi VR. The use of alendronate in the treatment of avascular necrosis of the femoral head: followup to eight years. J Bone Joint Surg Br 2009; 91: 1013-8.
30. Nishii T, Sugano N, Miki H, Hashimoto J, Yoshikawa H. Does alendronate prevent collapse in osteonecrosis of the femoral head? Clin Orthop Relat Res 2006; 443: 273-9.
31. Lai K-A, Shen W-J, Yang C-Y, Shao C-J, Hsu J-T, Lin RM. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am 2005; 87: 2155-9.
32. Grant SM, Goa KL. Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures. Drugs 1992; 43: 889-924.
33. Disch AC, Matziolis G, Perka C. The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous iloprost. J Bone Joint Surg Br 2005; 87: 560-4.
34. Aigner N, Meizer R, Stolz G, Petje G, Krasny C, Landsiedl F, Steinboeck G. Iloprost for the treatment of bone marrow edema in the hindfoot. Foot Ankle Clin 2003; 8: 683-93.
35. Aigner N, Petje G, Schneider W, Krasny C, Grill F, Landsiedl F. Juvenile bone-marrow oedema of the acetabulum treated by iloprost. J Bone Joint Surg Br 2002; 84: 1050-2.
36. Jager M, Tillmann FP, Thornhill TS, et al. Rationale for prostaglandin I2 in bone marrow oedema--from theory to application. Arthritis Res Ther 2008; 10: R120.
37. Kang P, Gao H, Pei F, Shen B, Yang J, Zhou Z. Effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Int J Exp Pathol 2010; 91: 235-43.
38. Nishida K, Yamamoto T, Motomura G, Jingushi S, Iwamoto Y. Pitavastatin may reduce risk of steroid-induced osteonecrosis in rabbits: a preliminary histological study. Clin Orthop Relat Res 2008; 466: 1054-8.
39. Davignon J, Mabile L. [Mechanisms of action of statins and their pleiotropic effects]. Ann Endocrinol (Paris) 2001; 62 (1Pt 2): 101-12.
40. Hatano H, Maruo A, Bolander ME, Sarkar G. Statin stimulates bone morphogenetic protein-2, aggrecan, and type 2 collagen gene expression and proteoglycan synthesis in rat chondrocytes. J Orthop Sci 2003; 8: 842-8.
41. Maeda T, Matsunuma A, Kurahashi I, Yanagawa T, Yoshida H, Horiuchi N. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J Cell Biochem 2004; 92: 458-71.
42. Morii H. [Effect of statins: HMG-CoA reductase inhibitor on bone metabolism]. Clin Calcium 2002; 12: 373-7.
43. Song C, Guo Z, Ma Q, et al. Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochem Biophys Res Commun 2003; 308: 458-62.
44. Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res 2001; 386: 173-8.
45. Ajmal M, Matas AJ, Kuskowski M, Cheng EY. Does statin usage reduce the risk of corticosteroid-related osteonecrosis in renal transplant population? Orthop Clin North Am 2009; 40: 235-9.
46. Camporesi EM, Vezzani G, Bosco G, Mangar D, Bernasek TL. Hyperbaric oxygen therapy in femoral head necrosis. J Arthroplasty 2010; 25 (suppl): 118-23.
47. Reis ND, Schwartz O, Militianu D, et al. Hyperbaric oxygen therapy as a treatment for stage-I avascular necrosis of the femoral head. J Bone Joint Surg Br 2003; 85: 371-5.
48. Alves EM, Angrisani AT, Santiago MB. The use of extracorporeal shock waves in the treatment of osteonecrosis of the femoral head: a systematic review. Clin Rheumatol 2009; 28: 1247-51.
49. Ma HZ, Zeng BF, Li XL. Upregulation of VEGF in subchondral bone of necrotic femoral heads in rabbits with use of extracorporeal shock waves. Calcif Tissue Int 2007; 81: 124-31.
50. Ma HZ, Zeng BF, Li XL, Chai YM. Temporal and spatial expression of BMP-2 in sub-chondral bone of necrotic femoral heads in rabbits by use of extracorporeal shock waves. Acta Orthop 2008; 79-1: 98-105.
51. Wang C-J, Wang F-S, Huang C-C, Yang KD, Weng L-H, Huang H-Y. Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone-grafting. J Bone Joint Surg Am 2005; 87: 2380-7.
52. Wang C-J, Wang F-S, Yang KD, et al. Treatment of osteonecrosis of the hip: comparison of extracorporeal shockwave with shockwave and alendronate. Arch Orthop Trauma Surg 2008; 128: 901-8.
53. Cane V, Botti P, Soana S. Pulsed magnetic fields improve osteoblast activity during the repair of an experimental osseous defect. J Orthop Res 1993; 11: 664-70.
54. Yen-Patton GP, Patton WF, Beer DM, Jacobson BS. Endothelial cell response to pulsed electromagnetic fields: stimulation of growth rate and angiogenesis in vitro. J Cell Physiol 1988; 134: 37-46.
55. Massari L, Fini M, Cadossi R, Setti S, Traina GC. Biophysical stimulation with pulsed electromagnetic fields in osteonecrosis of the femoral head. J Bone Joint Surg Am 2006; 88 (suppl 3): 56-60.
56. Hsu SL, Wang CJ, Lee MS, Chan YS, Huang CC, Yang KD. Cocktail therapy for femoral head necrosis of the hip. Arch Orthop Trauma Surg 2010; 130: 23-9.
57. Wong T, Wang CJ, Hsu SL, Chou WY, Lin PC, Huang CC. Cocktail therapy for hip necrosis in SARS patients. Chang Gung Med J 2008; 31: 546-53.